Skip to content

Clinical trials

Observational Demyelinating Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Demyelinating Diseases Phase: Observational Country / region: Germany Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20191
20201
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul1
Heinrich-Heine University, Duesseldorf1
Leipzig University Medical Center1
Shire1
SwanBio Therapeutics, Inc.1
University of Cologne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Demyelinating Diseases6
Brain Diseases, Metabolic, Inborn3
Metabolic Diseases3
Adrenoleukodystrophy2
Central Nervous System Diseases2
Hereditary Central Nervous System Demyelinating Diseases2
Metabolism, Inborn Errors2
Nervous System Diseases2
Peroxisomal Disorders2
Adrenal Insufficiency1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.